T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Table of Contents
1 Market Overview of T-Cell Immunotherapy
1.1 T-Cell Immunotherapy Market Overview
1.1.1 T-Cell Immunotherapy Product Scope
1.1.2 T-Cell Immunotherapy Market Status and Outlook
1.2 Global T-Cell Immunotherapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global T-Cell Immunotherapy Market Size by Region (2018-2029)
1.4 Global T-Cell Immunotherapy Historic Market Size by Region (2018-2023)
1.5 Global T-Cell Immunotherapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, T-Cell Immunotherapy Market Size (2018-2029)
1.6.1 North America T-Cell Immunotherapy Market Size (2018-2029)
1.6.2 Europe T-Cell Immunotherapy Market Size (2018-2029)
1.6.3 Asia-Pacific T-Cell Immunotherapy Market Size (2018-2029)
1.6.4 Latin America T-Cell Immunotherapy Market Size (2018-2029)
1.6.5 Middle East & Africa T-Cell Immunotherapy Market Size (2018-2029)
2 T-Cell Immunotherapy Market by Type
2.1 Introduction
2.1.1 CAR-T
2.1.2 TCR
2.1.3 TIL Therapies
2.2 Global T-Cell Immunotherapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global T-Cell Immunotherapy Historic Market Size by Type (2018-2023)
2.2.2 Global T-Cell Immunotherapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America T-Cell Immunotherapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe T-Cell Immunotherapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific T-Cell Immunotherapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America T-Cell Immunotherapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa T-Cell Immunotherapy Revenue Breakdown by Type (2018-2029)
3 T-Cell Immunotherapy Market Overview by Application
3.1 Introduction
3.1.1 Stomach Cancer
3.1.2 Lung Cancer
3.1.3 Colorectal Cancer
3.1.4 Esophagus Cancer
3.1.5 Pancreatic Cancer
3.1.6 Others
3.2 Global T-Cell Immunotherapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global T-Cell Immunotherapy Historic Market Size by Application (2018-2023)
3.2.2 Global T-Cell Immunotherapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America T-Cell Immunotherapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe T-Cell Immunotherapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific T-Cell Immunotherapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America T-Cell Immunotherapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa T-Cell Immunotherapy Revenue Breakdown by Application (2018-2029)
4 T-Cell Immunotherapy Competition Analysis by Players
4.1 Global T-Cell Immunotherapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in T-Cell Immunotherapy as of 2022)
4.3 Date of Key Players Enter into T-Cell Immunotherapy Market
4.4 Global Top Players T-Cell Immunotherapy Headquarters and Area Served
4.5 Key Players T-Cell Immunotherapy Product Solution and Service
4.6 Competitive Status
4.6.1 T-Cell Immunotherapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Adaptimmune
5.1.1 Adaptimmune Profile
5.1.2 Adaptimmune Main Business
5.1.3 Adaptimmune T-Cell Immunotherapy Products, Services and Solutions
5.1.4 Adaptimmune T-Cell Immunotherapy Revenue (US$ Million) & (2018-2023)
5.1.5 Adaptimmune Recent Developments
5.2 Altor Bioscience Corporation
5.2.1 Altor Bioscience Corporation Profile
5.2.2 Altor Bioscience Corporation Main Business
5.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Products, Services and Solutions
5.2.4 Altor Bioscience Corporation T-Cell Immunotherapy Revenue (US$ Million) & (2018-2023)
5.2.5 Altor Bioscience Corporation Recent Developments
5.3 Cellectis
5.3.1 Cellectis Profile
5.3.2 Cellectis Main Business
5.3.3 Cellectis T-Cell Immunotherapy Products, Services and Solutions
5.3.4 Cellectis T-Cell Immunotherapy Revenue (US$ Million) & (2018-2023)
5.3.5 Juno Therapeutics Recent Developments
5.4 Juno Therapeutics
5.4.1 Juno Therapeutics Profile
5.4.2 Juno Therapeutics Main Business
5.4.3 Juno Therapeutics T-Cell Immunotherapy Products, Services and Solutions
5.4.4 Juno Therapeutics T-Cell Immunotherapy Revenue (US$ Million) & (2018-2023)
5.4.5 Juno Therapeutics Recent Developments
5.5 Kite Pharma
5.5.1 Kite Pharma Profile
5.5.2 Kite Pharma Main Business
5.5.3 Kite Pharma T-Cell Immunotherapy Products, Services and Solutions
5.5.4 Kite Pharma T-Cell Immunotherapy Revenue (US$ Million) & (2018-2023)
5.5.5 Kite Pharma Recent Developments
5.6 Novartis
5.6.1 Novartis Profile
5.6.2 Novartis Main Business
5.6.3 Novartis T-Cell Immunotherapy Products, Services and Solutions
5.6.4 Novartis T-Cell Immunotherapy Revenue (US$ Million) & (2018-2023)
5.6.5 Novartis Recent Developments
5.7 Takara Bio
5.7.1 Takara Bio Profile
5.7.2 Takara Bio Main Business
5.7.3 Takara Bio T-Cell Immunotherapy Products, Services and Solutions
5.7.4 Takara Bio T-Cell Immunotherapy Revenue (US$ Million) & (2018-2023)
5.7.5 Takara Bio Recent Developments
5.8 Unum Therapeutics
5.8.1 Unum Therapeutics Profile
5.8.2 Unum Therapeutics Main Business
5.8.3 Unum Therapeutics T-Cell Immunotherapy Products, Services and Solutions
5.8.4 Unum Therapeutics T-Cell Immunotherapy Revenue (US$ Million) & (2018-2023)
5.8.5 Unum Therapeutics Recent Developments
6 North America
6.1 North America T-Cell Immunotherapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe T-Cell Immunotherapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific T-Cell Immunotherapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America T-Cell Immunotherapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa T-Cell Immunotherapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 T-Cell Immunotherapy Market Dynamics
11.1 T-Cell Immunotherapy Industry Trends
11.2 T-Cell Immunotherapy Market Drivers
11.3 T-Cell Immunotherapy Market Challenges
11.4 T-Cell Immunotherapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
Table 1. Global Market T-Cell Immunotherapy Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global T-Cell Immunotherapy Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global T-Cell Immunotherapy Market Size Share by Region (2018-2023)
Table 4. Global T-Cell Immunotherapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global T-Cell Immunotherapy Forecasted Market Size Share by Region (2024-2029)
Table 6. Global T-Cell Immunotherapy Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global T-Cell Immunotherapy Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global T-Cell Immunotherapy Revenue Market Share by Type (2018-2023)
Table 9. Global T-Cell Immunotherapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global T-Cell Immunotherapy Revenue Market Share by Type (2024-2029)
Table 11. North America T-Cell Immunotherapy Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America T-Cell Immunotherapy Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe T-Cell Immunotherapy Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe T-Cell Immunotherapy Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific T-Cell Immunotherapy Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific T-Cell Immunotherapy Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America T-Cell Immunotherapy Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America T-Cell Immunotherapy Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa T-Cell Immunotherapy Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa T-Cell Immunotherapy Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global T-Cell Immunotherapy Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global T-Cell Immunotherapy Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global T-Cell Immunotherapy Revenue Market Share by Application (2018-2023)
Table 24. Global T-Cell Immunotherapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global T-Cell Immunotherapy Revenue Market Share by Application (2024-2029)
Table 26. North America T-Cell Immunotherapy Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America T-Cell Immunotherapy Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe T-Cell Immunotherapy Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe T-Cell Immunotherapy Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific T-Cell Immunotherapy Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific T-Cell Immunotherapy Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America T-Cell Immunotherapy Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America T-Cell Immunotherapy Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa T-Cell Immunotherapy Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa T-Cell Immunotherapy Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global T-Cell Immunotherapy Revenue (US$ Million) by Players (2018-2023)
Table 37. Global T-Cell Immunotherapy Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in T-Cell Immunotherapy as of 2022)
Table 39. Date of Key Players Enter into T-Cell Immunotherapy Market
Table 40. Global T-Cell Immunotherapy Key Players Headquarters and Area Served
Table 41. T-Cell Immunotherapy Product Solution and Service
Table 42. Global T-Cell Immunotherapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Adaptimmune Basic Information List
Table 45. Adaptimmune Description and Business Overview
Table 46. Adaptimmune T-Cell Immunotherapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in T-Cell Immunotherapy Business of Adaptimmune (2018-2023)
Table 48. Adaptimmune Recent Developments
Table 49. Altor Bioscience Corporation Basic Information List
Table 50. Altor Bioscience Corporation Description and Business Overview
Table 51. Altor Bioscience Corporation T-Cell Immunotherapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in T-Cell Immunotherapy Business of Altor Bioscience Corporation (2018-2023)
Table 53. Altor Bioscience Corporation Recent Developments
Table 54. Cellectis Basic Information List
Table 55. Cellectis Description and Business Overview
Table 56. Cellectis T-Cell Immunotherapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in T-Cell Immunotherapy Business of Cellectis (2018-2023)
Table 58. Cellectis Recent Developments
Table 59. Juno Therapeutics Basic Information List
Table 60. Juno Therapeutics Description and Business Overview
Table 61. Juno Therapeutics T-Cell Immunotherapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in T-Cell Immunotherapy Business of Juno Therapeutics (2018-2023)
Table 63. Juno Therapeutics Recent Developments
Table 64. Kite Pharma Basic Information List
Table 65. Kite Pharma Description and Business Overview
Table 66. Kite Pharma T-Cell Immunotherapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in T-Cell Immunotherapy Business of Kite Pharma (2018-2023)
Table 68. Kite Pharma Recent Developments
Table 69. Novartis Basic Information List
Table 70. Novartis Description and Business Overview
Table 71. Novartis T-Cell Immunotherapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in T-Cell Immunotherapy Business of Novartis (2018-2023)
Table 73. Novartis Recent Developments
Table 74. Takara Bio Basic Information List
Table 75. Takara Bio Description and Business Overview
Table 76. Takara Bio T-Cell Immunotherapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in T-Cell Immunotherapy Business of Takara Bio (2018-2023)
Table 78. Takara Bio Recent Developments
Table 79. Unum Therapeutics Basic Information List
Table 80. Unum Therapeutics Description and Business Overview
Table 81. Unum Therapeutics T-Cell Immunotherapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in T-Cell Immunotherapy Business of Unum Therapeutics (2018-2023)
Table 83. Unum Therapeutics Recent Developments
Table 84. North America T-Cell Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 85. North America T-Cell Immunotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 86. Europe T-Cell Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 87. Europe T-Cell Immunotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 88. Asia-Pacific T-Cell Immunotherapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 89. Asia-Pacific T-Cell Immunotherapy Market Size by Region (2018-2023) & (US$ Million)
Table 90. Asia-Pacific T-Cell Immunotherapy Market Size by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific T-Cell Immunotherapy Market Share by Region (2018-2023)
Table 92. Asia-Pacific T-Cell Immunotherapy Market Share by Region (2024-2029)
Table 93. Latin America T-Cell Immunotherapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 94. Latin America T-Cell Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 95. Latin America T-Cell Immunotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 96. Middle East & Africa T-Cell Immunotherapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 97. Middle East & Africa T-Cell Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 98. Middle East & Africa T-Cell Immunotherapy Market Size by Country (2024-2029) & (US$ Million)
Table 99. T-Cell Immunotherapy Market Trends
Table 100. T-Cell Immunotherapy Market Drivers
Table 101. T-Cell Immunotherapy Market Challenges
Table 102. T-Cell Immunotherapy Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global T-Cell Immunotherapy Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global T-Cell Immunotherapy Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global T-Cell Immunotherapy Market Share by Regions: 2022 VS 2029
Figure 4. Global T-Cell Immunotherapy Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America T-Cell Immunotherapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe T-Cell Immunotherapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific T-Cell Immunotherapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America T-Cell Immunotherapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa T-Cell Immunotherapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of CAR-T
Figure 11. Global CAR-T Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of TCR
Figure 13. Global TCR Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of TIL Therapies
Figure 15. Global TIL Therapies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Global T-Cell Immunotherapy Market Size Share by Type: 2022 & 2029
Figure 17. North America T-Cell Immunotherapy Revenue Market Share by Type (2018-2029)
Figure 18. Europe T-Cell Immunotherapy Revenue Market Share by Type (2018-2029)
Figure 19. Asia-Pacific T-Cell Immunotherapy Revenue Market Share by Type (2018-2029)
Figure 20. Latin America T-Cell Immunotherapy Revenue Market Share by Type (2018-2029)
Figure 21. Middle East and Africa T-Cell Immunotherapy Revenue Market Share by Type (2018-2029)
Figure 22. Stomach Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Lung Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Colorectal Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. Esophagus Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 26. Pancreatic Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 27. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 28. Global T-Cell Immunotherapy Market Size Share by Application: 2022 & 2029
Figure 29. North America T-Cell Immunotherapy Revenue Market Share by Application (2018-2029)
Figure 30. Europe T-Cell Immunotherapy Revenue Market Share by Application (2018-2029)
Figure 31. Asia-Pacific T-Cell Immunotherapy Revenue Market Share by Application (2018-2029)
Figure 32. Latin America T-Cell Immunotherapy Revenue Market Share by Application (2018-2029)
Figure 33. Middle East and Africa T-Cell Immunotherapy Revenue Market Share by Application (2018-2029)
Figure 34. T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 35. Global Top 5 and Top 10 Players T-Cell Immunotherapy Market Share in 2022
Figure 36. North America T-Cell Immunotherapy Market Share by Country (2018-2029)
Figure 37. U.S. T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 38. Canada T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 39. Germany T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 40. France T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 41. U.K. T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 42. Italy T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 43. Russia T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 44. Nordic Countries T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 45. Asia-Pacific T-Cell Immunotherapy Market Share by Region (2018-2029)
Figure 46. China T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 47. Japan T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 48. South Korea T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 49. Southeast Asia T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 50. India T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 51. Australia T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 52. Latin America T-Cell Immunotherapy Market Share by Country (2018-2029)
Figure 53. Mexico T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 54. Brazil T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 55. Middle East & Africa T-Cell Immunotherapy Market Share by Country (2018-2029)
Figure 56. Turkey T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 58. UAE T-Cell Immunotherapy Market Size (2018-2029) & (US$ Million)
Figure 59. Bottom-up and Top-down Approaches for This Report

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cancer Immunomodulator Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......

Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125

According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......

Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......

Global Kaposi Sarcoma Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107

Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......

Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs